A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy

Clinical trial NCT07289477 · RECRUITING

Trial details

NCT number: NCT07289477
Sponsor: iRegene Therapeutics Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Start date: 2026-01-05
Primary completion: 2027-10-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.